Subtype
Lung Neuroendocrine Carcinoma
CI-CAN-00003107Explore in graph →
389 active trials6 approved drugs6 evidence items
- NCIt
- C45569
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003107Explore in graph →
Clinical trials
1,113 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (158)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013(CBPC) | unknown | Phase 3 | 164 | University Hospital, AngersOTHER_GOV | 1 | Apr 25, 2016 | clinicaltrials |
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer(ICE) | completed | Phase 2 | 42 | University Hospital Southampton NHS Foundation TrustOTHER | 1 |
| Apr 14, 2016 |
| clinicaltrials |
| NCT02738723 | SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC | unknown | Phase 2 | 50 | Third Military Medical UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02736916 | HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer | unknown | N/A | 3 | General Hospital of Ningxia Medical UniversityOTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT01977235 | Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer(TDICC) | unknown | Phase 2 | 110 | Third Military Medical UniversityOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00930891 | Bevacizumab in Extensive Small Cell Lung Cancer(CPC) | completed | Phase 2 / Phase 3 | 143 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00643396 | Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 30 | AHS Cancer Control AlbertaOTHER | 1 | Feb 26, 2016 | clinicaltrials |
| NCT02688673 | DC Vaccine Combined With CIK Cells in Patients With SCLC | unknown | Phase 1 / Phase 2 | 30 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 0 | Feb 23, 2016 | clinicaltrials |
| NCT01784107 | A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 45 | Gachon University Gil Medical CenterOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00812266 | Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) | terminated | Phase 3 | 281 | Danish Oncological Lung Cancer GroupOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT00401609 | G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients(G-Step) | completed | Phase 1 / Phase 2 | 85 | National Cancer Institute, NaplesOTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT01533181 | Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 2 | Jan 14, 2016 | clinicaltrials |
| NCT00299390 | Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer | terminated | Phase 2 | 10 | BayerINDUSTRY | 0 | Dec 31, 2015 | clinicaltrials |
| NCT01159327 | Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy | terminated | Phase 2 | 13 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 11, 2015 | clinicaltrials |
| NCT01713296 | Pazopanib in Relapsed and Refractory Small Cell Lung Cancer | completed | Phase 2 | 58 | Hellenic Oncology Research GroupOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT00755157 | Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer | withdrawn | Phase 2 | 0 | University Hospital of CreteOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01487499 | Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)(SCLC) | terminated | Phase 3 | 4 | University of FloridaOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT01421316 | Hair-sparing Whole Brain Radiotherapy | terminated | Phase 2 | 29 | University Hospital, GhentOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT00316186 | First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin | completed | Phase 2 | 33 | GlaxoSmithKlineINDUSTRY | 2 | May 7, 2015 | clinicaltrials |
| NCT00470054 | Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00521144 | Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT01037023 | Regulatory Hycamtin(Oral) PMS(Hycamtin PMS) | completed | — | 92 | GlaxoSmithKlineINDUSTRY | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01500720 | Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer | completed | Phase 2 | 179 | SanofiINDUSTRY | 16 | Apr 13, 2015 | clinicaltrials |
| NCT00346385 | BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 97 | ImmunoGen, Inc.INDUSTRY | 2 | Mar 26, 2015 | clinicaltrials |
| NCT01486459 | A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer(TULIP) | terminated | N/A | 7 | Barwon HealthOTHER_GOV | 1 | Mar 18, 2015 | clinicaltrials |
| NCT01591512 | A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer | terminated | — | 4 | Fujirebio Diagnostics, Inc.INDUSTRY | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00658580 | Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer | completed | Phase 3 | 361 | European Lung Cancer Working PartyOTHER | 4 | Feb 12, 2015 | clinicaltrials |
| NCT00759824 | A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide | completed | Phase 2 | 64 | European Lung Cancer Working PartyOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02323737 | Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer | completed | Phase 2 | 62 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 30, 2014 | clinicaltrials |
| NCT01943578 | Value of Physical Capacity Tests in Lung Cancer | completed | — | 80 | Rigshospitalet, DenmarkOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT02262897 | The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT01426841 | Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer | unknown | Phase 1 | 10 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT00912392 | Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 138 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Sep 3, 2014 | clinicaltrials |
| NCT00132704 | An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation | completed | — | 149 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00118235 | Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00084487 | Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy | terminated | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00182689 | Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 89 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00066742 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00079040 | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | May 14, 2014 | clinicaltrials |
| NCT00773955 | R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | May 12, 2014 | clinicaltrials |
| NCT00616109 | Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC | completed | Phase 2 | 16 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00086827 | Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2014 | clinicaltrials |
| NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00088933 | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00997061 | SCOT Registry: Small Cell Lung Cancer Treatment and Outcome(SCOT) | completed | — | 500 | GlaxoSmithKlineINDUSTRY | 14 | Feb 3, 2014 | clinicaltrials |
| NCT02039518 | Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients | unknown | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00349492 | A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer | completed | Phase 3 | 372 | Clinical Research Center for Solid Tumor, KoreaOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00052949 | Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 91 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 25, 2016source: clinicaltrials